Last update:
Immunology
Daylight can boost the immune system's ability to fight infections
A breakthrough study, led by scientists at Waipapa Taumata Rau, University of Auckland, has uncovered how daylight can boost the immune system's ability to fight infections.
3 hours ago
0
45
Neuroscience
Researchers contribute to new toolkit for battling brain disorders
New studies stemming from the Armamentarium consortium outline findings that advance tools based on Adeno-associated virus (AAV) vectors. An announcement about the work explains how an AAV "acts like a shuttle capable of ...
3 hours ago
0
21
Medical research news
Organ-specific inflammation masquerades as relapse in CAR T-cell remission
Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have identified a previously undocumented, organ-specific toxicity linked to CD19-targeted CAR T-cell therapy in autoimmune disease. The syndrome, termed ...
Skin cancer is a growing threat to older adult men as global population ages
Researchers at the First Affiliated Hospital of Chongqing Medical University in China have uncovered a sharply rising burden of skin cancer in older adults driven largely by population growth and affecting men twice as often.
Single-cell RNA sequencing of bone metastases from multiple cancer types reveals three distinct immune archetypes
Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at Baylor College of Medicine ...
5 hours ago
0
9
Millions still lack access to glasses—study shows minimal progress in coverage since 2010
Millions of people across the world still lack access to basic eye care such as glasses, according to a new study led by Professor Rupert Bourne of Anglia Ruskin University (ARU).
5 hours ago
0
66
US excess deaths continue to rise even after the COVID-19 pandemic, study finds
There were over 1.5 million "missing Americans" in 2022 and 2023, deaths that would have been averted if US mortality rates matched those of peer countries. Excess US deaths have been increasing for decades, with working-age ...
6 hours ago
0
93
Weight loss linked to nerve cells in the brain
Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes, ...
6 hours ago
0
46
Reactivation of specific memories can indirectly strengthen related ones, study finds
Most humans can recall specific events and past experiences for long periods of time. This capability, referred to as episodic memory, is known to be in great part supported by the activity of neurons in the hippocampus and ...
Millions of HealthCare.gov participants face coverage loss due to burdensome reenrollment policies
Researchers from the University of Pittsburgh, University of South Carolina and Emory University have published findings in JAMA Health Forum from a recent study on coverage retention and plan switching among Americans who ...
6 hours ago
0
20
Novel long noncoding RNA may serve as therapeutic target for prostate cancer
Northwestern Medicine investigators have discovered that a novel long noncoding RNA (lncRNA), which are usually 200 nucleotides longer than typical RNAs and are widely expressed in cells, could serve as a prognostic biomarker ...
6 hours ago
0
0
Novel immune cell population may offer alternative target for tuberculosis vaccines
There is no highly effective vaccine against tuberculosis (TB), which remains an infection of global concern. Charles Kyriakos Vorkas, MD, an infectious diseases physician-scientist at the Renaissance School of Medicine (RSOM) ...
6 hours ago
0
0
Vascularized stem cell islet organoids offer improved model for diabetes research
Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model of hormone-secreting cells in the pancreas. The advance, published in Developmental Cell, promises ...
6 hours ago
0
0
Venous thromboembolism in children: Rivaroxaban found effective and safe even with extended use
Venous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer. Treatment or prevention of thrombosis poses an additional challenge in everyday ...
7 hours ago
0
41
Noninvasive ultrasound method for measuring central venous pressure validated in clinical pilot study
In a clinical pilot study, researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH) have validated a novel, noninvasive method for measuring central venous pressure (CVP) using ...
4 hours ago
0
0
Timing and consistency of activity linked to better fitness in older adults
Some people spring into action at dawn, while others prefer a slower start to their day. Whether you rise with a grin or a groan, scientists say your internal clock—known as the circadian rhythm—might influence that behavior ...
4 hours ago
0
2
Study uncovers source of genetic variation influencing childhood brain tumors
Researchers still do not have a comprehensive picture of the factors that influence gene expression in human cancers. Understanding gene expression in cancer is important because it can reveal how the disease begins, develops ...
7 hours ago
0
13
Cell therapy for patients with amyotrophic lateral sclerosis shows promise in human trials
Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise ...
5 hours ago
0
0
Blood test offers faster, less invasive diagnosis for rare genetic diseases in children and infants
Researchers from the University of Melbourne and Murdoch Children's Research Institute (MCRI) have developed a blood test capable of rapidly diagnosing rare genetic diseases in babies and children, eliminating the need for ...
9 hours ago
0
1
Experimental drug may benefit some patients with rare form of ALS
When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's unwaveringly honest. "Patients always ask me, 'What can I hope to get out of this?"' Shneider ...
23 hours ago
0
21
